Literature DB >> 7669347

Two-stage model for integration of the lysis protein E of phi X174 into the cell envelope of Escherichia coli.

P Schön1, G Schrot, G Wanner, W Lubitz, A Witte.   

Abstract

As a tool for determining the topology of the small, 91-amino acid phi X174 lysis protein E within the envelope complex of Escherichia coli, a lysis active fusion of protein E with streptavidin (E-FXa-StrpA) was used. The E-FXa-StrpA fusion protein was visualised using immune electron microscopy with gold-conjugated anti-streptavidin antibodies within the envelope complex in different orientations. At the distinct areas of lysis characteristic for protein E, the C-terminal end of the fusion protein was detected at the surface of the outer membrane, whereas at other areas the C-terminal portion of the protein was located at the cytoplasmic side of the inner membrane. These results suggest that a conformational change of protein E is necessary to induce the lysis process, an assumption supported by proteinase K protection studies. The immune electron microscopic data and the proteinase K accessibility studies of the E-FXa-StrA fusion protein were used for the working model of the E-mediated lysis divided into three phases: phase 1 is characterised by integration of protein E into the inner membrane without a cytoplasmic status in a conformation with its C-terminal part facing the cytoplasmic side; phase 2 is characterised by a conformational change of the protein transferring the C-terminus across the inner membrane; phase 3 is characterised by a fusion of the inner and outer membranes and is associated with a transfer of the C-terminal domain of protein E towards the surface of the outer membrane of E. coli.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7669347     DOI: 10.1111/j.1574-6976.1995.tb00203.x

Source DB:  PubMed          Journal:  FEMS Microbiol Rev        ISSN: 0168-6445            Impact factor:   16.408


  9 in total

1.  Autotransporter-based antigen display in bacterial ghosts.

Authors:  Anna Hjelm; Bill Söderström; David Vikström; Wouter S P Jong; Joen Luirink; Jan-Willem de Gier
Journal:  Appl Environ Microbiol       Date:  2014-11-14       Impact factor: 4.792

2.  Online monitoring of Escherichia coli ghost production.

Authors:  W Haidinger; M P Szostak; W Jechlinger; W Lubitz
Journal:  Appl Environ Microbiol       Date:  2003-01       Impact factor: 4.792

Review 3.  The Bacterial Ghost platform system: production and applications.

Authors:  Timo Langemann; Verena Juliana Koller; Abbas Muhammad; Pavol Kudela; Ulrike Beate Mayr; Werner Lubitz
Journal:  Bioeng Bugs       Date:  2010 Sep-Oct

4.  Functional display of ice nucleation protein InaZ on the surface of bacterial ghosts.

Authors:  Johannes Kassmannhuber; Mascha Rauscher; Lea Schöner; Angela Witte; Werner Lubitz
Journal:  Bioengineered       Date:  2017-01-25       Impact factor: 3.269

5.  Escherichia coli ghost production by expression of lysis gene E and Staphylococcal nuclease.

Authors:  W Haidinger; U B Mayr; M P Szostak; S Resch; W Lubitz
Journal:  Appl Environ Microbiol       Date:  2003-10       Impact factor: 4.792

6.  A Novel and Efficient High-Yield Method for Preparing Bacterial Ghosts.

Authors:  Yi Ma; Liu Cui; Meng Wang; Qiuli Sun; Kaisheng Liu; Jufang Wang
Journal:  Toxins (Basel)       Date:  2021-06-13       Impact factor: 4.546

7.  A novel one-step expression and immobilization method for the production of biocatalytic preparations.

Authors:  Ilka Sührer; Timo Langemann; Werner Lubitz; Dirk Weuster-Botz; Kathrin Castiglione
Journal:  Microb Cell Fact       Date:  2015-11-14       Impact factor: 5.328

8.  Fed-Batch Production of Bacterial Ghosts Using Dielectric Spectroscopy for Dynamic Process Control.

Authors:  Andrea Meitz; Patrick Sagmeister; Werner Lubitz; Christoph Herwig; Timo Langemann
Journal:  Microorganisms       Date:  2016-03-24

Review 9.  Bacteria from Infectious Particles to Cell Based Anticancer Targeted Drug Delivery Systems.

Authors:  Mounir M Salem-Bekhit; Abdullah M E Youssof; Fars K Alanazi; Fadilah Sfouq Aleanizy; Alsuwyeh Abdulaziz; Ehab I Taha; Amro Abd Al Fattah Amara
Journal:  Pharmaceutics       Date:  2021-11-23       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.